Barclays downgraded Illumina (ILMN) to Underweight from Equal Weight. Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed ...

Barclays downgraded Illumina (ILMN) to Underweight from Equal Weight with a price target of $100, down from $130. The firm sees greater risk to management’s ability to deliver on their plan due ...

Minecraft builds show the game's potential with new blocks. YouTuber Bubbaflubba's attention to detail in recreating the Florence Cathedral is impressive. The Minecraft builder used WorldEdit to ...

Feb 4 (Reuters) - Shares of genetic testing company Illumina (ILMN.O), opens new tab and Calvin Klein-owner PVH Corp (PVH.N), opens new tab fell on Tuesday after ...

Feb 6 (Reuters) - Gene sequencing machine maker Illumina (ILMN.O), opens new tab forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling ...

Illumina has struggled to boost sales and consistently deliver positive earnings. Its Q4 report was largely a disappointment, and management's 2025 guidance came in below Wall Street's ...

Released March 15, 1985, “Vision Quest” arrived smack in the middle of the ‘80s teen movie renaissance. It was preceded by ...

That morning, Barclays changed its recommendation on Illumina stock to underweight (read: sell) from the previous equal weight (hold). It also pulled the lever on a significant price target ...

China's "blacklist of entities" now has two more entries -- Illumina and fashion conglomerate PVH-- after its government put the companies on notice late Monday. The move is clearly a retaliatory ...

(Reuters) - Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling subdued demand for its genetic tests and diagnostic tools ...

(RTTNews) - Below are the earnings highlights for Illumina Inc. (ILMN): Earnings: $187 million in Q4 vs. -$176 million in the same period last year. EPS: $1.17 in Q4 vs. -$1.11 in the same period ...

Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that incorporate more than 140 invention disclosures and 60 patent families.